Dextran prodrugs — structure and stability in relation to therapeutic activity
- 28 February 1989
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 3 (1), 103-154
- https://doi.org/10.1016/0169-409x(89)90006-9
Abstract
No abstract availableKeywords
This publication has 196 references indexed in Scilit:
- In vitro drug release from macromolecule-drug conjugates of 3'-(7-carboxyheptanoyl)-5-fluoro-2'-deoxyuridine with decylenediamine-dextran T70 or poly-L-lysine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987
- Absorption characteristics of macromolecular prodrugs of mitomycin C following intramuscular administration.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Preparation of dextran T70-methotrexate conjugate and dextran T70-mycophenolic acid conjugate, and in vitro effect of dextran T70-methotrexate on dihydrofolate reductase.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Lymph node localization of non-specific antibody-coated liposomesLife Sciences, 1985
- Plasma disposition and in vivo and in vitro antiumor activities of mitomycin C-dextran conjugate in relation to the mode of action.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Production of a monoclonal antibody-bleomycin conjugate utilizing dextran T-40 and the antigen-targeting cytotoxicity of the conjugateBiochemical and Biophysical Research Communications, 1983
- Requirement of macromolecular complex formation for selective lymphatic transfer of bleomycin from large intestine by bifunctional delivery system.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Dextran hypersensitivityImmunology Today, 1982
- Structure and properties of synthetic polymers of pharmacological and biomedical interestDie Makromolekulare Chemie, 1981
- Dextran-linked insulin: A soluble high molecular weight derivative with biological activity invivo and invitroBiochemical and Biophysical Research Communications, 1972